Integrating study for clinical imaging of cerebral functions and hemodynamic parameters.

脑功能与血流动力学参数临床影像的整合研究。

基本信息

项目摘要

To investigate relationship between pathological vascular change and hemodynamic alteration in the brain, regional cerebral blood flow (rCBF) and metabolic rate of oxygen (CMRO_2) were measured in patients with chronic cerebrovascular disease (CVD) using PET. ^<15>O-water PET studies were performed in 104 patients with major cerebral arterial stenoocclusive disease (mean age=61.0±14.0 y) at baseline and 10 min after the acetazolamide (ACZ) injection to evaluate regional changes in rCBF. All patients also underwent ^<15>O-gas PET studies using the steady-state method to measure total cerebral blood volume (CBV), oxygen extraction fraction (OEF) and CMRO_2. They were evaluated misery perfusion (stage II ischemia) defined by elevation of and residual vasodilatory capacity. The mean of % increase in rCBF induced by ACZ was significant in both hemispheres of all patients with CVD although there was a subgroup of patients who showed a significant reduction of the rCBF increase in the affecte … More d hemisphere. The absolute OEF in the affected cortical regions was not correlated with % change in rCBF, whereas asymmetry index of OEF in the same regions showed a weak correlation. Sixteen patients had cerebral regions with a significant increase in OEF, and 7 of them (43.8 %) showed a significant decrease in vascular reserve evaluated by the ACZ test. Of the 31 patients who had a reduction of rCBF increase in the affected hemisphere, only 7 patients (22.6 %) showed an OEF increase in the same region. The reduced rCBF response to the ACZ injection is not necessarily associated with misery perfusion in patients with CVD. The two hemodynamic parameters were not equivalent in the critical stage of chronic hemodynamic impairment. We also proposed a new parameter of arterial cerebral perfusion pressure (CPPa) defined by the ratio of rCBF to arterial-to-capillary blood volume (V_0) for assessment of impaired cerebral circulation. In 40 patients with severer vasoocclusiove disease, about half of them showed a reduction of vasodilatory capacity in the affected cerebral territories. In this severely impaired cerebral circulation group, strokes were significantly associated with reduction of CPPa in the ACZ test. Based on these findings from PET studies, MRI studies for evaluation of impaired cerebral circulation were designed and an excellent correlation was obtained between results from PET and MRI. We also applied the same methods to SPECT studies. Less
为探讨慢性脑血管病(CVD)患者脑内病理性血管改变与血流动力学改变的关系,采用PET检测脑局部血流量(rCBF)和氧代谢率(cro_2)。对104例脑动脉狭窄性疾病患者(平均年龄61.0±14.0岁)在基线和注射乙酰唑胺(ACZ)后10分钟进行O-water PET研究,以评估rCBF的区域变化。所有患者均采用稳态法进行^<15>O-gas PET研究,测量脑总血容量(CBV)、氧提取分数(OEF)和cmoro_2。通过血管舒张能力的升高和剩余来评估患者的急性灌注(II期缺血)。ACZ诱导的rCBF的平均%增加在所有CVD患者的两个半球都是显著的,尽管有一个亚组的患者在受影响的半球显示rCBF的增加显著减少。受影响皮质区域的绝对OEF与rCBF %变化无相关性,而同一区域的OEF不对称指数呈弱相关性。16例患者脑区OEF显著升高,其中7例(43.8%)ACZ试验显示血管储备显著降低。在31例受影响半球rCBF增加减少的患者中,只有7例患者(22.6%)在同一区域显示OEF增加。CVD患者对ACZ注射的rCBF反应降低并不一定与灌注不良相关。两项血流动力学参数在慢性血流动力学损害的关键阶段不相等。我们还提出了一个新的动脉脑灌注压(CPPa)参数,该参数由rCBF与动脉-毛细血管血容量(V_0)的比值定义,用于评估脑循环受损。在40例患有严重血管闭塞性疾病的患者中,大约一半的患者在受影响的大脑区域表现出血管舒张能力的降低。在这个严重脑循环受损的组中,卒中与ACZ测试中CPPa的降低显著相关。基于PET研究的这些发现,设计了用于评估脑循环受损的MRI研究,并在PET和MRI结果之间获得了良好的相关性。我们也将同样的方法应用于SPECT研究。少

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamauchi H, Okazawa H, et al.: "Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease"Journal of Neurology, Neurosurgery and Psychiatry. 75. 33-37 (2004)
Yamauchi H、Okazawa H 等人:“症状性颈动脉疾病中的氧提取分数和乙酰唑胺反应性”神经病学、神经外科和精神病学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A simplified autoradiographic method with a-[^<14>C]methyl-tryptophan to measure serotonin synthesis rate in the rat brain.
一种用α-[14C]甲基色氨酸测量大鼠脑中血清素合成率的简化放射自显影方法。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Okazawa H;Nishizawa S;Tsuchida T;Yonekura Y;Diksic M.
  • 通讯作者:
    Diksic M.
Hidehiko Okazawa et al.: "Differences of vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease"Journal of Nuclear Medicine. 44. 1371-1378 (2003)
Hidehiko Okazawa 等:“脑血管疾病患者乙酰唑胺引起的血管舒张能力差异和脑血流变化”核医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamauchi H, Okazawa H, et al.: "The effect of deafferentation on cerebral blood flow response to acetazolamide"American Journal of Neuroradiology. 25. 92-96 (2004)
Yamauchi H、Okazawa H 等人:“传入神经阻滞对乙酰唑胺脑血流反应的影响”美国神经放射学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
The effect of acetazolamide on the changes of cerebral blood flow and oxygen metabolism during visual stimulation
乙酰唑胺对视觉刺激时脑血流及氧代谢变化的影响
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yamauchi H;Okazawa H;Kishibe Y;Sugimoto K;Takahashi M
  • 通讯作者:
    Takahashi M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YONEKURA Yoshiharu其他文献

YONEKURA Yoshiharu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YONEKURA Yoshiharu', 18)}}的其他基金

Quantitative analysis of dopaminergic synaptic function in human brain.
人脑多巴胺能突触功能的定量分析。
  • 批准号:
    09470198
  • 财政年份:
    1997
  • 资助金额:
    $ 23.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on Quantitative Analysis of Dopamine Receptor Function in Brain.
脑中多巴胺受体功能的定量分析研究。
  • 批准号:
    08457242
  • 财政年份:
    1996
  • 资助金额:
    $ 23.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Three-dimensional Combined Analysis System of Brain Function.
脑功能三维联合分析系统开发。
  • 批准号:
    07557067
  • 财政年份:
    1995
  • 资助金额:
    $ 23.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)

相似海外基金

Mrgprb2 mediated neuroinflammation after cerebral ischemia
Mrgprb2介导脑缺血后的神经炎症
  • 批准号:
    10644182
  • 财政年份:
    2023
  • 资助金额:
    $ 23.05万
  • 项目类别:
Sexually Dimorphic Amygdala Dysfunction in a Mouse Model of Global Cerebral Ischemia
全脑缺血小鼠模型中的性二形性杏仁核功能障碍
  • 批准号:
    10828626
  • 财政年份:
    2023
  • 资助金额:
    $ 23.05万
  • 项目类别:
Astrocyte-specific TLR4 signaling and Blood Brain Barrier permeability following acute focal cerebral ischemia
急性局灶性脑缺血后星形胶质细胞特异性 TLR4 信号传导和血脑屏障通透性
  • 批准号:
    10572987
  • 财政年份:
    2023
  • 资助金额:
    $ 23.05万
  • 项目类别:
ContinuOuS Monitoring Tool for Delayed Cerebral IsChemia (COSMIC)
迟发性脑缺血持续监测工具 (COSMIC)
  • 批准号:
    10736589
  • 财政年份:
    2023
  • 资助金额:
    $ 23.05万
  • 项目类别:
Fluoxetine recovery of synaptic dysfunction following juvenile global cerebral ischemia
氟西汀恢复青少年全脑缺血后突触功能障碍
  • 批准号:
    10509753
  • 财政年份:
    2022
  • 资助金额:
    $ 23.05万
  • 项目类别:
Novel neuroprotective therapy by inhibition of ferroptosis in cerebral ischemia-reperfusion injury
通过抑制脑缺血再灌注损伤中铁死亡的新型神经保护疗法
  • 批准号:
    22K16676
  • 财政年份:
    2022
  • 资助金额:
    $ 23.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Discovery of Plasma Biomarkers of Delayed Cerebral Ischemia after Subarachnoid Hemorrhage
蛛网膜下腔出血后迟发性脑缺血血浆生物标志物的发现
  • 批准号:
    10358411
  • 财政年份:
    2022
  • 资助金额:
    $ 23.05万
  • 项目类别:
Discovery of Plasma Biomarkers of Delayed Cerebral Ischemia after Subarachnoid Hemorrhage
蛛网膜下腔出血后迟发性脑缺血血浆生物标志物的发现
  • 批准号:
    10589874
  • 财政年份:
    2022
  • 资助金额:
    $ 23.05万
  • 项目类别:
Estrous cycle stage at the time of global cerebral ischemia: Implications for hypothalamic-pituitary-gonadal axis function and estrous cycle regularity
全脑缺血时的动情周期阶段:对下丘脑-垂体-性腺轴功能和动情周期规律的影响
  • 批准号:
    572356-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 23.05万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Innovative Research of Neuroprotection for Delayed Cerebral Ischemia Associated with Cerebral Vasospasm after Subarachnoid Hemorrhage using Novel Hemoglobin-based Oxygen Carrier
新型血红蛋白氧载体对蛛网膜下腔出血后迟发性脑血管痉挛相关迟发性脑缺血的神经保护创新研究
  • 批准号:
    22K09275
  • 财政年份:
    2022
  • 资助金额:
    $ 23.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了